Warberg Asset Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Warberg Asset Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$889K	Buy	+94,797	New	+$513K	0.16%	53

Other funds holding RVMDW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Warberg Asset Management's RVMDW Position: Q2 2026 in Review

Warberg Asset Management opened a new position in Revolution Medicines Inc Warrant (RVMDW) in Q2 2026: 94,797 shares worth $889K. The stake represents 0.16% of the portfolio and ranks #53 among its holdings.

22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

Warberg Asset Management held 94,797 shares of Revolution Medicines Inc Warrant worth $889K as of Q2 2026.
Revolution Medicines Inc Warrant was a new Warberg Asset Management position in Q2 2026.
Revolution Medicines Inc Warrant made up 0.16% of Warberg Asset Management's portfolio in Q2 2026, its #53 holding.
22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Warberg Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.